EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) said President, Chief Executive Officer and Chair Eric M. Green plans to retire once a successor is appointed, with the transition expected in the second half of 2026.
The company said its board has engaged an executive recruiting firm to lead the search and will maintain continuity during the transition process.
Green, who has served as CEO since April 2015 and became chair in May 2022, said the decision follows more than a decade in the role.
“After serving 11 years as the Company’s 6th CEO … it is time for someone else to take over the leadership of West,” Green said.
The company reaffirmed its previously issued 2026 guidance alongside the announcement.
Robert F. Friel, lead independent director, said Green’s tenure included significant financial growth.
“His eleven-year tenure is marked by exceptional revenue and enterprise value growth,” Friel said, adding that sales more than doubled and total shareholder return reached about 350%.
West said Green also oversaw product innovation and supported global vaccine delivery efforts during the COVID-19 pandemic.
The company, which provides injectable drug delivery systems and services, reported $3.07 billion in net sales in fiscal 2025.
West said it operates more than 50 sites worldwide and employs over 10,000 people.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.